COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL

Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study. 160 patients received carvedilol and 160 patients – metoprolol. Both randomized...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Reeks:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Onderwerpen:
arterial hypertension
overweight
obesity
beta-blockers
carvedilol
metoprolol
Online toegang:https://www.rpcardio.com/jour/article/view/617
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items